|
US6309669B1
(en)
*
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
|
US6406689B1
(en)
|
1995-10-03 |
2002-06-18 |
Frank W. Falkenberg |
Compositions and methods for treatment of tumors and metastatic diseases
|
|
US5942253A
(en)
*
|
1995-10-12 |
1999-08-24 |
Immunex Corporation |
Prolonged release of GM-CSF
|
|
AU713276B2
(en)
*
|
1996-05-23 |
1999-11-25 |
Samyang Corporation |
Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof
|
|
KR0181252B1
(ko)
*
|
1996-12-31 |
1999-03-20 |
박원훈 |
에멀젼 방법에 의한 다공성 매트릭스형 서방성 제제의 제조방법
|
|
US20050074495A1
(en)
*
|
1997-06-17 |
2005-04-07 |
Fziomed, Inc. |
Compositions of polyacids and methods for their use in reducing adhesions
|
|
US20040096422A1
(en)
*
|
1997-06-17 |
2004-05-20 |
Schwartz Herbert E. |
Compositions of polyacids and polyethers and methods for their use in reducing pain
|
|
US6869938B1
(en)
*
|
1997-06-17 |
2005-03-22 |
Fziomed, Inc. |
Compositions of polyacids and polyethers and methods for their use in reducing adhesions
|
|
US7192984B2
(en)
*
|
1997-06-17 |
2007-03-20 |
Fziomed, Inc. |
Compositions of polyacids and polyethers and methods for their use as dermal fillers
|
|
WO1999009956A1
(en)
*
|
1997-08-29 |
1999-03-04 |
Corixa Corporation |
Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of using thereof
|
|
US6045824A
(en)
|
1997-09-18 |
2000-04-04 |
Skyepharma Inc. |
Sustained-release liposomal anesthetic compositions
|
|
AU752802C
(en)
*
|
1997-11-14 |
2006-04-13 |
Pacira Pharmaceuticals, Inc. |
Production of multivesicular liposomes
|
|
US6730322B1
(en)
|
1998-04-30 |
2004-05-04 |
Acusphere, Inc. |
Matrices formed of polymer and hydrophobic compounds for use in drug delivery
|
|
US6423345B2
(en)
*
|
1998-04-30 |
2002-07-23 |
Acusphere, Inc. |
Matrices formed of polymer and hydrophobic compounds for use in drug delivery
|
|
CN1313873A
(zh)
*
|
1998-07-13 |
2001-09-19 |
表达遗传学公司 |
作为可溶性,生物可降解基因送递载体的聚－l－赖氨酸的聚酯类似物
|
|
WO2000003660A1
(en)
*
|
1998-07-17 |
2000-01-27 |
Skyepharma, Inc. |
Biodegradable compositions for the controlled release of encapsulated substances
|
|
US6916490B1
(en)
*
|
1998-07-23 |
2005-07-12 |
UAB Research Center |
Controlled release of bioactive substances
|
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
|
US6395300B1
(en)
*
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
US6521431B1
(en)
|
1999-06-22 |
2003-02-18 |
Access Pharmaceuticals, Inc. |
Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
|
|
EP1074248A1
(en)
*
|
1999-07-08 |
2001-02-07 |
Arnold Hilgers |
Delivery system for biological material
|
|
US6465425B1
(en)
|
2000-02-10 |
2002-10-15 |
Alkermes Controlled Therapeutics, Inc. |
Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
|
|
US6284235B1
(en)
*
|
2000-02-11 |
2001-09-04 |
National Starch And Chemical Company Investment Holding Corporation |
Bioadhesive composition
|
|
WO2001074397A1
(fr)
*
|
2000-03-31 |
2001-10-11 |
Kirin Beer Kabushiki Kaisha |
Preparation en poudre destinee a etre administree par les muqueuses comprenant un medicament de forme polymere et presentant une stabilite de conservation amelioree
|
|
US6264987B1
(en)
|
2000-05-19 |
2001-07-24 |
Alkermes Controlled Therapeutics Inc. Ii |
Method for preparing microparticles having a selected polymer molecular weight
|
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
|
US6362308B1
(en)
|
2000-08-10 |
2002-03-26 |
Alkermes Controlled Therapeutics Inc. Ii |
Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
|
|
US6911204B2
(en)
|
2000-08-11 |
2005-06-28 |
Favrille, Inc. |
Method and composition for altering a B cell mediated pathology
|
|
SG143058A1
(en)
*
|
2000-08-11 |
2008-06-27 |
Favrille Inc |
Method and composition for altering a t cell mediated pathology
|
|
US6824822B2
(en)
*
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
|
US6471995B1
(en)
|
2000-09-27 |
2002-10-29 |
Alkermes Controlled Therapeutics, Inc. Ii |
Apparatus and method for preparing microparticles using liquid-liquid extraction
|
|
CA2424896A1
(en)
|
2000-10-06 |
2002-04-11 |
Jagotec Ag |
A controlled-release, parenterally administrable microparticle preparation
|
|
EP2316490A3
(en)
|
2000-10-31 |
2012-02-01 |
PR Pharmaceuticals, Inc. |
Methods and compositions for enhanced delivery of bioactive molecules
|
|
DE10055857A1
(de)
*
|
2000-11-10 |
2002-08-22 |
Creative Peptides Sweden Ab Dj |
Neue pharmazeutische Depotformulierung
|
|
JP2005513081A
(ja)
|
2000-12-13 |
2005-05-12 |
パーデュー・リサーチ・ファウンデイション |
溶媒交換による薬剤のマイクロカプセル化
|
|
ES2250502T3
(es)
*
|
2000-12-13 |
2006-04-16 |
Merckle Gmbh |
Microparticulas con un perfil de liberacion mejorado y procedimient0 para su preparacion.
|
|
US20020114843A1
(en)
*
|
2000-12-27 |
2002-08-22 |
Ramstack J. Michael |
Preparation of microparticles having improved flowability
|
|
US6652886B2
(en)
*
|
2001-02-16 |
2003-11-25 |
Expression Genetics |
Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
|
|
KR20040007583A
(ko)
|
2001-05-23 |
2004-01-24 |
다나베 세이야꾸 가부시키가이샤 |
연골 질환의 재생치료용 조성물
|
|
WO2002094321A1
(en)
|
2001-05-23 |
2002-11-28 |
Tanabe Seiyaku Co., Ltd. |
Compositions for promoting healing of bone fracture
|
|
US20030124149A1
(en)
*
|
2001-07-06 |
2003-07-03 |
Shalaby Shalaby W. |
Bioactive absorbable microparticles as therapeutic vaccines
|
|
US20030124196A1
(en)
*
|
2001-08-22 |
2003-07-03 |
Susan Weinbach |
Pulsatile release compositions and methods for enhanced intestinal drug absorption
|
|
US20030083286A1
(en)
*
|
2001-08-22 |
2003-05-01 |
Ching-Leou Teng |
Bioadhesive compositions and methods for enhanced intestinal drug absorption
|
|
WO2003051113A1
(en)
*
|
2001-12-14 |
2003-06-26 |
The University Of Wyoming |
Methods and compositions for controlled release of drugs
|
|
WO2003061626A1
(en)
*
|
2002-01-18 |
2003-07-31 |
Control Delivery Systems, Inc. |
Polymeric gel system for the controlled delivery of codrugs
|
|
US20050260259A1
(en)
*
|
2004-04-23 |
2005-11-24 |
Bolotin Elijah M |
Compositions for treatment with glucagon-like peptide, and methods of making and using the same
|
|
US7635463B2
(en)
*
|
2002-02-27 |
2009-12-22 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials
|
|
AU2003219922B2
(en)
*
|
2002-02-27 |
2009-09-10 |
Pharmain Corporation |
Compositions for delivery of therapeutics and other materials, and methods of making and using the same
|
|
AU2003230320A1
(en)
*
|
2002-05-09 |
2003-11-11 |
Peptron Co., Ltd |
Sustained release formulation of protein and preparation method thereof
|
|
US7037983B2
(en)
|
2002-06-14 |
2006-05-02 |
Kimberly-Clark Worldwide, Inc. |
Methods of making functional biodegradable polymers
|
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
|
WO2004035086A2
(en)
*
|
2002-10-16 |
2004-04-29 |
Hunter Samuel F |
Method for treatment of demyelinating central nervous system disease using gm-csf
|
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
US9040664B2
(en)
|
2003-04-11 |
2015-05-26 |
Antriabio, Inc. |
Materials and methods for preparing protein-polymer conjugates
|
|
JP4763459B2
(ja)
*
|
2003-05-29 |
2011-08-31 |
株式会社東京大学Ｔｌｏ |
安定化高分子ミセル
|
|
GB0317999D0
(en)
*
|
2003-07-31 |
2003-09-03 |
Univ Liege |
Improvements in or relating to drug delivery systems
|
|
EP1682571A4
(en)
*
|
2003-10-27 |
2006-12-06 |
Medvet Science Pty Ltd |
BICOORDIN PATTERN AND METHODS OF USE
|
|
EP1586334A1
(en)
*
|
2004-04-15 |
2005-10-19 |
TRASTEC scpa |
G-CSF conjugates with peg
|
|
CN1968700A
(zh)
*
|
2004-04-15 |
2007-05-23 |
阿尔克姆斯有限公司 |
聚合物基的持续释放装置
|
|
WO2006019950A2
(en)
*
|
2004-07-16 |
2006-02-23 |
Nektar Therapeutics Al, Corporation |
Conjugates of a gm-csf moiety and a polymer
|
|
EP1674077A1
(en)
*
|
2004-12-27 |
2006-06-28 |
Université de Liège |
Mucoadhesive pharmaceutical compositions comprising chemoattractants
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
US9205046B2
(en)
*
|
2005-04-25 |
2015-12-08 |
The Governing Council Of The University Of Toronto |
Enhanced stability of inverse thermal gelling composite hydrogels
|
|
BRPI0614257A2
(pt)
*
|
2005-08-04 |
2011-03-15 |
Nektar Therapeutics Al Corp |
conjugados de uma porção de g-csf e um polìmero
|
|
US20070081972A1
(en)
*
|
2005-09-30 |
2007-04-12 |
The University Of Iowa Research Foundation |
Polymer-based delivery system for immunotherapy of cancer
|
|
US7585675B2
(en)
*
|
2005-11-15 |
2009-09-08 |
University Of Kansas Medical Center |
Inhibition of HIV and SHIV replication with antisense interleukin-4
|
|
ES2798263T3
(es)
|
2005-12-08 |
2020-12-10 |
Insmed Inc |
Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
|
|
KR101529318B1
(ko)
|
2005-12-19 |
2015-06-16 |
파마인 코포레이션 |
치료제를 전달하기 위한 소수성 코어 담체 조성물, 이조성물의 제조 방법 및 그 조성물의 이용 방법
|
|
ITMI20061545A1
(it)
*
|
2006-08-02 |
2008-02-03 |
Mediolanum Pharmaceuticals Ltd |
Particelle in grado di rilasciare il principio attivo per un periodo prolungato di tempo
|
|
PL2359808T3
(pl)
|
2006-08-09 |
2013-10-31 |
Intarcia Therapeutics Inc |
Osmotyczne systemy dostawcze i zespoły tłokowe
|
|
WO2008118712A1
(en)
*
|
2007-03-22 |
2008-10-02 |
Alkermes, Inc. |
Coacervation process
|
|
EP2157967B1
(en)
|
2007-04-23 |
2013-01-16 |
Intarcia Therapeutics, Inc |
Suspension formulations of insulinotropic peptides and uses thereof
|
|
WO2008137717A1
(en)
|
2007-05-04 |
2008-11-13 |
Transave, Inc. |
Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
US20080317865A1
(en)
*
|
2007-06-20 |
2008-12-25 |
Alkermes, Inc. |
Quench liquids and washing systems for production of microparticles
|
|
US7960336B2
(en)
*
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
|
US8563527B2
(en)
*
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
|
US20090176892A1
(en)
|
2008-01-09 |
2009-07-09 |
Pharmain Corporation |
Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
|
EP2240155B1
(en)
|
2008-02-13 |
2012-06-06 |
Intarcia Therapeutics, Inc |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
GB0814302D0
(en)
*
|
2008-08-05 |
2008-10-01 |
Coretherapix Slu |
Compounds and methods
|
|
US20100189763A1
(en)
*
|
2009-01-23 |
2010-07-29 |
Heather Nettles |
Controlled release systems from polymer blends
|
|
WO2010093452A2
(en)
*
|
2009-02-11 |
2010-08-19 |
University Of Houston |
Reducible polymers for non-viral gene delivery
|
|
KR101233352B1
(ko)
*
|
2009-04-22 |
2013-02-25 |
(주)비씨월드제약 |
유전자 재조합 과립구-대식세포 집락 촉진인자를 함유하는 정제
|
|
SG176239A1
(en)
*
|
2009-06-05 |
2012-01-30 |
Univ Nanyang Tech |
Multi-phase microparticles and method of manufacturing multi-phase microparticles
|
|
WO2011001657A1
(ja)
|
2009-07-01 |
2011-01-06 |
独立行政法人科学技術振興機構 |
ポリイオンデンドリマー、及びそれよりなるハイドロゲル
|
|
EP3323423B1
(en)
|
2009-09-28 |
2020-06-17 |
Intarcia Therapeutics, Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
|
AU2010314994B2
(en)
|
2009-11-09 |
2016-10-06 |
Spotlight Technology Partners Llc |
Fragmented hydrogels
|
|
JP5864429B2
(ja)
|
2009-11-09 |
2016-02-17 |
スポットライト テクノロジー パートナーズ エルエルシーＳｐｏｔｌｉｇｈｔ Ｔｅｃｈｎｏｌｏｇｙ Ｐａｒｔｎｅｒｓ Ｌｌｃ |
架橋ヒドロゲル組成物、ヒドロゲル組成物の形成方法、及びキット
|
|
US8546353B2
(en)
|
2010-05-06 |
2013-10-01 |
Glykos Finland Oy |
Compounds and combinations
|
|
EP2384759A1
(en)
*
|
2010-05-06 |
2011-11-09 |
Suomen Punainen Risti Veripalvelu |
Sulphated hyaluronic acid in combination with G-CSF for use in mobilising blood stem cells
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
PL2852391T3
(pl)
|
2012-05-21 |
2022-04-11 |
Insmed Incorporated |
Układy do leczenia infekcji płuc
|
|
CA2891487A1
(en)
|
2012-11-29 |
2014-06-05 |
Insmed Incorporated |
Stabilized vancomycin formulations
|
|
EP3662924A1
(en)
*
|
2014-03-07 |
2020-06-10 |
Reponex Pharmaceuticals A/S |
Compositions for treating lung infections by airway administration
|
|
MX384843B
(es)
|
2014-05-15 |
2025-03-14 |
Insmed Inc |
Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas.
|
|
US10105415B2
(en)
|
2014-07-24 |
2018-10-23 |
Reponex Pharmaceuticals A/S |
Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
ES2968262T3
(es)
|
2015-06-03 |
2024-05-08 |
I2O Therapeutics Inc |
Sistemas de colocación de implantes
|
|
KR20240037175A
(ko)
|
2016-05-16 |
2024-03-21 |
인타르시아 세라퓨틱스 인코포레이티드 |
글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
AU2018206539A1
(en)
|
2017-01-03 |
2019-07-18 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
|
|
EP3773505B1
(en)
|
2018-03-30 |
2026-04-29 |
Insmed Incorporated |
Methods for continuous manufacture of liposomal drug products
|
|
EP3787602A4
(en)
|
2018-05-02 |
2022-03-23 |
Insmed Incorporated |
PROCESS FOR THE MANUFACTURE OF LIPOSOMAL DRUG FORMULATIONS
|
|
WO2020002650A1
(en)
*
|
2018-06-29 |
2020-01-02 |
Targovax Asa |
A formulation
|
|
WO2020066679A1
(ja)
*
|
2018-09-28 |
2020-04-02 |
株式会社カネカ |
樹脂組成物およびその成形体
|
|
DE102019126672B4
(de)
*
|
2019-10-02 |
2021-07-01 |
Universität Rostock |
Wirkstoffdepotsystem sowie Kit zur in situ Polymerisation des Wirkstoffdepotsystems
|
|
WO2021146215A1
(en)
|
2020-01-13 |
2021-07-22 |
Durect Corporation |
Sustained release drug delivery systems with reduced impurities and related methods
|
|
CA3203561A1
(en)
|
2021-01-12 |
2022-07-21 |
Adrian Neil Verity |
Sustained release drug delivery systems and related methods
|
|
US12151024B2
(en)
|
2021-01-22 |
2024-11-26 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
US11033495B1
(en)
|
2021-01-22 |
2021-06-15 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
US11278494B1
(en)
|
2021-01-22 |
2022-03-22 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
US11357727B1
(en)
|
2021-01-22 |
2022-06-14 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
US12285419B2
(en)
|
2021-10-14 |
2025-04-29 |
Pacira Pharmaceuticals, Inc. |
Bupivacaine multivesicular liposome formulations and uses thereof
|
|
US12251472B1
(en)
|
2024-05-20 |
2025-03-18 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
US12156940B1
(en)
|
2024-05-20 |
2024-12-03 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
|
US12280149B1
(en)
|
2024-05-20 |
2025-04-22 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|